ShareHope Medicine Co., Ltd. (TPEX:8403)
28.60
+0.20 (0.70%)
Apr 2, 2025, 1:30 PM CST
ShareHope Medicine Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 200.1 | 124.56 | 293.95 | 232.66 | 247.71 | Upgrade
|
Depreciation & Amortization | 307.56 | 308.13 | 299.65 | 298.45 | 208.89 | Upgrade
|
Other Amortization | - | 13.41 | 9.65 | 6.07 | 7.5 | Upgrade
|
Loss (Gain) From Sale of Assets | -94.96 | -23.91 | -9.2 | -3.71 | -0.69 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 51.47 | 25.65 | - | Upgrade
|
Loss (Gain) From Sale of Investments | -8.32 | -8.89 | -2.9 | -38.59 | 41.04 | Upgrade
|
Loss (Gain) on Equity Investments | -0.44 | 1.85 | 0.4 | 0.22 | 2.22 | Upgrade
|
Stock-Based Compensation | - | - | - | 3.27 | 31.22 | Upgrade
|
Provision & Write-off of Bad Debts | 10.95 | 3.09 | -2.03 | -15.52 | 2.89 | Upgrade
|
Other Operating Activities | -149.97 | -70.99 | -62.51 | -75.2 | 201.6 | Upgrade
|
Change in Accounts Receivable | 123.66 | -147.32 | -144.99 | 19.55 | -128.13 | Upgrade
|
Change in Inventory | 3.86 | -0.52 | 18.84 | 40.62 | -90.12 | Upgrade
|
Change in Accounts Payable | -82.43 | 44.08 | 150.85 | -88.82 | 118.7 | Upgrade
|
Change in Unearned Revenue | 36.41 | 7.04 | -1.76 | -4.3 | - | Upgrade
|
Change in Other Net Operating Assets | -79.76 | 6.6 | 41.04 | -40.27 | 74.91 | Upgrade
|
Operating Cash Flow | 266.68 | 257.13 | 642.47 | 360.1 | 717.74 | Upgrade
|
Operating Cash Flow Growth | 3.71% | -59.98% | 78.41% | -49.83% | 42.80% | Upgrade
|
Capital Expenditures | -83.07 | -250.31 | -1,266 | -137.51 | -357.89 | Upgrade
|
Sale of Property, Plant & Equipment | 58.11 | 40.53 | 110.57 | 3.57 | 1.55 | Upgrade
|
Cash Acquisitions | - | - | - | - | -3.86 | Upgrade
|
Divestitures | 2.81 | - | - | - | 1.3 | Upgrade
|
Sale (Purchase) of Intangibles | -9.95 | -26.9 | -18.07 | -14.56 | -6.11 | Upgrade
|
Investment in Securities | -28.96 | 58.85 | -182.25 | -7.25 | -13.64 | Upgrade
|
Other Investing Activities | 96.17 | -49.78 | -17.85 | -164.96 | -15.13 | Upgrade
|
Investing Cash Flow | 35.11 | -227.6 | -1,374 | -320.71 | -393.78 | Upgrade
|
Short-Term Debt Issued | 25.62 | 101.21 | 30.52 | 19.99 | 93.06 | Upgrade
|
Long-Term Debt Issued | 2.55 | 158.3 | 1,194 | 15.84 | - | Upgrade
|
Total Debt Issued | 28.17 | 259.51 | 1,225 | 35.83 | 93.06 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -67.63 | -0.01 | Upgrade
|
Long-Term Debt Repaid | -236.28 | -151.33 | -476.96 | -230.89 | -82.38 | Upgrade
|
Total Debt Repaid | -236.28 | -151.33 | -476.96 | -298.52 | -82.39 | Upgrade
|
Net Debt Issued (Repaid) | -208.11 | 108.18 | 747.56 | -262.69 | 10.67 | Upgrade
|
Repurchase of Common Stock | -9 | -227.43 | - | - | - | Upgrade
|
Common Dividends Paid | -53.86 | -60.02 | -57.16 | -102.8 | -2.11 | Upgrade
|
Other Financing Activities | 43.76 | -1.11 | 15.89 | 202.09 | 312.92 | Upgrade
|
Financing Cash Flow | -227.22 | -180.39 | 706.28 | -163.41 | 321.47 | Upgrade
|
Foreign Exchange Rate Adjustments | 2.05 | -1.3 | 2.83 | -5.37 | -2.5 | Upgrade
|
Net Cash Flow | 76.61 | -152.16 | -21.99 | -129.38 | 642.93 | Upgrade
|
Free Cash Flow | 183.6 | 6.83 | -623.51 | 222.59 | 359.85 | Upgrade
|
Free Cash Flow Growth | 2589.38% | - | - | -38.14% | -9.69% | Upgrade
|
Free Cash Flow Margin | 4.24% | 0.18% | -15.07% | 5.78% | 8.78% | Upgrade
|
Free Cash Flow Per Share | 1.40 | 0.05 | -4.72 | 1.68 | 2.67 | Upgrade
|
Cash Interest Paid | - | 48.9 | 36.85 | 19.73 | 11.67 | Upgrade
|
Cash Income Tax Paid | - | 57.65 | 104.31 | 110.92 | 26.3 | Upgrade
|
Levered Free Cash Flow | 73.25 | -106.81 | -622.19 | 85.96 | 182.65 | Upgrade
|
Unlevered Free Cash Flow | 109.72 | -74.25 | -600.52 | 98.52 | 191.72 | Upgrade
|
Change in Net Working Capital | 216.38 | 176.8 | -170.52 | 216.11 | 12.96 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.